| BE0042-25MG
| InVivoMab anti-mouse IL-2
| 25 mg
| BioXCell
| in vivo IL-2 neutralization, in vitro IL-2 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0026-100MG
| InVivoMab anti-mouse CD103
| 100 mg
| BioXCell
| In vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0075-1-25MG
| InVivoMab anti-mouse Ly6G
| 25 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0031-50MG
| InVivoMab anti-mouse OX40 (CD134)
| 50 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0004-1-5MG
| InVivoMab anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0033-2-5MG
| InVivoMab anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0004-1-25MG
| InVivoMab anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0033-1-5MG
| InVivoMab anti-mouse OX40L (CD134L)
| 5 mg
| BioXCell
| in vivo blocking of OX40/OX40L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0000-100MG
| InVivoMab anti-mouse CD1d (CD1.1)
| 100 mg
| BioXCell
| in vivo CD1d neutralization, in vitro CD1d neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0051-25MG
| InVivoMab anti-mouse IL-12 p40
| 25 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0032-25MG
| InVivoMab anti-mouse CTLA-4 (CD152)
| 25 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0069-50MG
| InVivoMab anti-mouse 2C TCR
| 50 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0028-5MG
| InVivoMab anti-mouse ICOSL (CD275)
| 5 mg
| BioXCell
| in vivo ICOSL neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0004-2-5MG
| InVivoMab anti-human CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0019-1MG
| InVivoMab anti-mouse CD45RB
| 1 mg
| BioXCell
| in vivo anti-CD45RB–mediated tolerance induction,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0004-2-25MG
| InVivoMab anti-human CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0001-1-25MG
| InVivoMab anti-mouse CD3?
| 25 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0014-5MG
| InVivoMab anti-human CD25 (IL-2R?)
| 5 mg
| BioXCell
| in vivo regulatory T cell depletion in humanized m
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0001-1-5MG
| InVivoMab anti-mouse CD3?
| 5 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0009-25MG
| InVivoMab anti-mouse CD18
| 25 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0059-1MG
| InVivoMab anti-mouse ICOS
| 1 mg
| BioXCell
| in vivo blocking of ICOS/ICOSL signaling, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0002-5MG
| InVivoMab anti-mouse CD3
| 5 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0022-5MG
| InVivoMab anti-mouse CD70
| 5 mg
| BioXCell
| In vivo CD70 blockade, In vitro CD70 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0046-50MG
| InVivoMab anti-mouse IL-6
| 50 mg
| BioXCell
| in vivo IL-6 neutralization, in vitro IL-6 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0075-1MG
| InVivoMab anti-mouse Ly6G/Ly6C (Gr-1)
| 1 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0045-50MG
| InVivoMab anti-mouse IL-4
| 50 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0079-50MG
| InVivoMab anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 50 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0002-1MG
| InVivoMab anti-mouse CD3
| 1 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0005-1-25MG
| InVivoMab anti-mouse LFA-1? (CD11a)
| 25 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0055-25MG
| InVivoMab anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0039-50MG
| InVivoMab anti-mouse/human CD44
| 50 mg
| BioXCell
| in vivo CD44 neutralization, in vitro CD44 neutral
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0069-25MG
| InVivoMab anti-mouse 2C TCR
| 25 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0067-1MG
| InVivoMab anti-mouse B220
| 1 mg
| BioXCell
| in vivo B cell depletion, in vitro B cell negative
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0086-5MG
| InVivoMab mouse IgG2b isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BE0050-1MG
| InVivoMab anti-mouse IL-10R (CD210)
| 1 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0020-2-5MG
| InVivoMab anti-human CD54 (ICAM-1)
| 5 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0019-50MG
| InVivoMab anti-mouse CD45RB
| 50 mg
| BioXCell
| in vivo anti-CD45RB–mediated tolerance induction,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0007-5MG
| InVivoMab anti-mouse/human CD11b
| 5 mg
| BioXCell
| in vivo CD11b neutralization, ILC2 cell purificati
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0066-50MG
| InVivoMab anti-mouse Thy1.2 (CD90.2)
| 50 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0003-1-1MG
| InVivoMab anti-mouse CD4
| 1 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0000-25MG
| InVivoMab anti-mouse CD1d (CD1.1)
| 25 mg
| BioXCell
| in vivo CD1d neutralization, in vitro CD1d neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0043-100MG
| InVivoMab anti-mouse IL-2
| 100 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0069-5MG
| InVivoMab anti-mouse 2C TCR
| 5 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0071-50MG
| InVivoMab anti-mouse/human VLA-4 (CD49d)
| 50 mg
| BioXCell
| in vivo VLA-4 neutralization, in vitro VLA-4 neutr
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0055-5MG
| InVivoMab anti-mouse IFN?
| 5 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0032-5MG
| InVivoMab anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0049-100MG
| InVivoMab anti-mouse IL-10
| 100 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0026-5MG
| InVivoMab anti-mouse CD103
| 5 mg
| BioXCell
| In vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0028-1MG
| InVivoMab anti-mouse ICOSL (CD275)
| 1 mg
| BioXCell
| in vivo ICOSL neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0039-1MG
| InVivoMab anti-mouse/human CD44
| 1 mg
| BioXCell
| in vivo CD44 neutralization, in vitro CD44 neutral
|
| Rat
| mouse/huma
| Solicitar Precio
| Solicitar
|